Spagnolo, Paolo
Tweddell, David
Cela, Enis
Daley, Mark
Clarson, Cheril
Rupar, C. Anthony
Stranges, Saverio
Bravo, Michael
Cepinskas, Gediminas
Fraser, Douglas D.
Funding for this research was provided by:
Academic Medical Organization of Southwestern Ontario
London Health Sciences Foundation
Article History
Received: 11 October 2024
Accepted: 12 December 2024
First Online: 20 December 2024
Declarations
:
: This study was approved by the Western University, Human Research Ethics Board (HREB; #17908E; #15996E). Consent was obtained from the legal guardians of all pediatric patients admitted with DKA, and both guardian consent and patient assent were secured for T1D control patients.
: Not applicable.
: The authors declare no competing interests.